
Coral Genomics
Coral Genomics is a YC Summer 2018 (S18) company. Based in San Francisco, CA, USA. Team of 5.
About Coral Genomics
Summary
Coral Genomics develops clinical laboratory tests that predict which treatments will work best for individual autoimmune disease patients. The tests combine molecular, functional, and clinical data to guide treatment decisions, replacing trial-and-error prescribing. The company also targets a distinct patient subpopulation that does not respond to existing autoimmune therapies, an area current diagnostics and treatments do not address.
From the Y Combinator listing
New clinical tests for managing autoimmune treatments.
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 5
- Acquired
- Early
Founders (2)
- Atray Dixit
- Jacob Borrajo
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works